Application Note: WB: 1:1000. IHC-P: 1:50-1:100. FCM: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 106
Form: Liquid
Buffer (with preservative): PBS, 0.09% Sodium azide.
Concentration: Batch dependent (Please refer to the vial label for the specific concentration.)
Background: The inter-alpha-trypsin inhibitors (ITI) are a family of structurally related plasma serine protease inhibitors involved in extracellular matrix stabilization and in prevention of tumor metastasis. The ITI family contains multiple proteins made up of a light chain (see MIM 176870) and a variable number of heavy chains (Salier et al., 1987 [PubMed 2446322]; Himmelfarb et al., 2004 [PubMed 14744536]).[supplied by OMIM, Nov 2009]
Uniprot ID: P19823
Antigen Species: Human
Immunogen: A KLH conjugated synthetic peptide from the C-terminal region of human ITIH2 (858-886 aa).
Purification: Purified by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
Conjugation: Unconjugated
Full Name: inter-alpha-trypsin inhibitor heavy chain 2
Deutsch
English
